Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Axsome Therapeutics, Inc. (AXSM)
Sector: Healthcare; Industry: Biotechnology

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the phase III clinical trial for the treatment resistant depression and depressive disorders; and phase II/III clinical trials in agitation associated with Alzheimer's disease, as well as completed phase II clinical trial for the treatment of smoking cessation. The company was founded in 2012 and is based in New York, New York.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-06-29 Coleman Mark Director Buy 650 $78.50 $51,025 No
2020-06-29 Pizzie Nick Chief Financial Officer Buy 777 $76.64 $59,549 No
2019-09-26 Pizzie Nick Chief Financial Officer Buy 2,180 $24.80 $54,064 No
2019-06-26 Coleman Mark Director Buy 16,200 $23.10 $374,280 No
2019-06-11 Pizzie Nick Chief Financial Officer Buy 1,920 $20.80 $39,936 No
2019-05-23 Saad Mark E Director Buy 3,500 $22.33 $78,155 No
2019-05-13 Coleman Mark Director Buy 4,650 $21.44 $99,696 No
2019-03-19 Pizzie Nick Chief Financial Officer Buy 5,400 $12.58 $67,939 No
2019-03-19 Coleman Mark Director Buy 5,100 $12.18 $62,118 No
2018-06-19 Pizzie Nick Chief Financial Officer Buy 31,000 $3.10 $96,080 No
2015-12-23 Kaye Randall Chief Medical Officer Buy 1,000 $9.03 $9,026 No

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.